Front. Oncol. Frontiers in Oncology Front. Oncol. 2234-943X Frontiers Media S.A. 10.3389/fonc.2021.738970 Oncology Retraction Retraction: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling Frontiers Editorial Office * Frontiers Media SA, Lausanne, Switzerland

Approved by: Giuseppe Giaccone, Cornell University, United States

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org

This article was submitted to Gastrointestinal Cancers, a section of the journal Frontiers in Oncology

 31 08 2021 2021 11 738970 09 07 2021 12 07 2021 Copyright © 2021 Frontiers Editorial Office 2021 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Retraction of the Original Research Article RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling by Luo C, Zhu X, Luo Q, Bu F, Huang C, Zhu J, Zhao J, Zhang W, Lin K, Hu C, Zong Z, Luo H, Huang J and Zhu Z (2020). Front. Oncol. 10:1044. doi: 10.3389/fonc.2020.01044

The journal retracts the 20 July 2020 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors did not agree to this retraction.